Constitutively active PIK3CA mutations are expressed by lymphatic and vascular endothelial cells in capillary lymphatic venous malformation
Timothy D. Le Cras(Cincinnati Children's Hospital Medical Center), Elisa Boscolo(Cincinnati Children's Hospital Medical Center)
Cited by 55
Related Papers
Rapamycin improves TIE2-mutated venous malformation in murine model and human subjects
|Journal of Clinical Investigation|2015|240
Inhibition of PI3K by PX-866 Prevents Transforming Growth Factor-α–Induced Pulmonary Fibrosis
|American Journal Of Pathology|2009|62
A xenograft model for venous malformation
|Angiogenesis|2018|44
MEK inhibition reduced vascular tumor growth and coagulopathy in a mouse model with hyperactive GNAQ
|Nature Communications|2023|29
How we use angiopoietin‐2 in the diagnosis and management of vascular anomalies
|Pediatric Blood & Cancer|2024|14